Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 | Straits Research
November 21, 2024 09:55 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Nov. 21, 2024 (GLOBE NEWSWIRE) -- "Liquid biopsy" isolates and detects circulating nucleic acids (DNA or RNA), exosomes, and circulating tumor cells to diagnose primary...
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024 16:05 ET
|
Immuneering Corporation
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
BC Organizations Launch In-Home Danger Radon Gas Public Awareness Campaign
November 04, 2024 08:00 ET
|
British Columbia Real Estate Association
Vancouver, Nov. 04, 2024 (GLOBE NEWSWIRE) -- November is Radon Action Month, and the BC Real Estate Association (BCREA), BC Lung Foundation, and Real Estate Foundation of BC are announcing the...
WAKE RADIOLOGY TO HOST LUNG CANCER SCREENING EVENT SATURDAY, NOVEMBER 9
October 31, 2024 09:40 ET
|
Wake Radiology UNC Health Rex
Raleigh, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 9, Wake Radiology UNC Health Rex, in partnership with the American College of Radiology, is participating in National Lung...
New Treatments, Novel Research Drive Better Survival Rates for Canadians with Lung Cancer, Offering Hope to Thousands: Lung Health Foundation
October 31, 2024 08:26 ET
|
Lung Health Foundation
New treatments and novel research are driving better survival rates for Canadians with Lung Cancer, offering hope to thousands of patients.
Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes
October 23, 2024 13:30 ET
|
Lung Health Foundation
TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF), the premier resource on lung health for all Canadians, is urging all Canadians to act on findings presented in the 2024...
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
October 22, 2024 16:01 ET
|
Genelux Corporation
– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint inhibitor compared to docetaxel in recurrent...
“A meaningful first step in acknowledging decades of harm”: Lung Health Foundation Applauds Landmark $32.5 Billion Legal Settlement Against Tobacco Companies
October 18, 2024 14:10 ET
|
Lung Health Foundation
Lung Health Foundation- Canada’s premier resource on lung health research, education and advocacy- applauds Landmark Settlement Against Tobacco Companies
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
October 10, 2024 23:16 ET
|
Burning Rock Biotech Limited
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Oncology Collaboration and Licensing Agreements Analysis Report 2024: SEC-Linked Oncology Contract Documents Reveal In-Depth Deal Structures and Payment Clauses
September 30, 2024 05:03 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offeringThe report provides access to deal...